Literature DB >> 10025935

Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.

H K Choi1, P A Merkel, J W Tervaert, R M Black, R T McCluskey, J L Niles.   

Abstract

We describe a patient who presented with Wegener's granulomatosis associated with antineutrophil cytoplasmic antibodies (ANCA) directed against proteinase 3 (PR3) with a cytoplasmic immunofluorescence pattern (cANCA), whose ANCA type changed to antimyeloperoxidase antibodies with a perinuclear immunofluorescence pattern (pANCA) when treated with propylthiouracil, and changed back to anti-PR3 antibodies with cANCA after the medication was discontinued. The patient developed flares of vasculitis symptoms associated with rises in either type of ANCA. Tests for antimyeloperoxidase ANCA were repeatedly negative before the drug was started, strongly implicating the drug as the cause of the episode. This case demonstrates that patients with idiopathic ANCA-positive vasculitis may quickly develop a superimposed drug-associated ANCA-positive vasculitis. Iatrogenic vasculitis should be suspected when a patient with idiopathic vasculitis with one type of ANCA develops the other type of ANCA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025935     DOI: 10.1002/1529-0131(199902)42:2<384::AID-ANR22>3.0.CO;2-X

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

Review 1.  Clinical utility of testing for antineutrophil cytoplasmic antibodies.

Authors:  D Vassilopoulos; G S Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 2.  Drug-induced vasculitis.

Authors:  Marta Lucia Cuellar
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

3.  Antineutrophil cytoplasmic antibody-positive vasculitis associated with propylthiouracil therapy.

Authors:  S Dinmezel; C Ogus; T Ozdemir
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

4.  A fatal case of propylthiouracil-induced ANCA-positive vasculitis.

Authors:  Nick Batchelor; Aaron Holley
Journal:  MedGenMed       Date:  2006-10-12

Review 5.  Laboratory testing in the evaluation and diagnosis of vasculitis.

Authors:  M L Cuellar; L R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.686

6.  Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.

Authors:  Branka Bonaci-Nikolic; Milos M Nikolic; Sladjana Andrejevic; Svetlana Zoric; Mirjana Bukilica
Journal:  Arthritis Res Ther       Date:  2005-07-13       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.